| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32f57a53515b98afbb284cb39a2f17f7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-05 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-002 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B59-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-56 |
| filingDate |
2016-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64273a90f1093784c5e167be40808a9e |
| publicationDate |
2017-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2017137383-A1 |
| titleOfInvention |
Deuterated cftr potentiators |
| abstract |
This invention relates to compounds of Formula I: n n n n n n n n n n and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a CFTR potentiator. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10479766-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11708331-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10738036-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10759721-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10196384-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10894773-B2 |
| priorityDate |
2011-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |